feed,title,long_url,short_url
Benzinga,HUTCHMED Cancer Med Cuts Death Risk By 34% In Metastatic Colorectal Cancer,https://benzinga.com/general/biotech/22/09/28799756/hutchmed-cancer-med-cuts-death-risk-by-34-in-metastatic-colorectal-cancer,https://bit.ly/3Bn1Io1
Benzinga,A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%,https://benzinga.com/general/biotech/22/09/28798040/morgan-stanley-boosts-price-target-on-sarepta,https://bit.ly/3QsO5YW
